We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Brainjuicer | LSE:BJU | London | Ordinary Share | GB00B1GVQH21 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 787.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMBJU
RNS Number : 6651U
BrainJuicer Group PLC
20 January 2017
Press Release 20 January 2017
BrainJuicer Group PLC (AIM: BJU)
("BrainJuicer", or "the Company")
Trading Update
BrainJuicer (AIM: BJU) today releases the following update on trading during the 12 month period ended 31st December 2016.
BrainJuicer traded strongly during 2016, regaining momentum after the modest growth of the 2 previous years. For the 12 month period, Gross Profit, our main top line indicator, increased by some 27% to approximately GBP25.6m, driven primarily by continued strong progress by our US business and an encouraging recovery in Continental Europe. Excluding the impact of exchange rate movements the increase in Gross Profit was some 15%.
In terms of products, our Advertising Testing and Brand Tracking services again delivered strong growth. In aggregate Gross Profit from these comparatively high margin and scalable quantitative services rose by around 80%, and represented around 39% of BrainJuicer's total Gross Profit, compared with 27% in 2015.
Our System1 creative advertising agency, launched in early 2016, is making an encouraging start with costs net of initial revenues in 2016 on budget at GBP0.3m.
Cost increases, and in particular central overheads, were held well below the rate of Gross Margin growth. Even after a much higher level of bonus payments, compared with a negligible payout in 2015, Pre-tax profit for 2016 is expected to be some 37% higher at around GBP6.2m, (2015: GBP4.5m) after a share-based payments charge of GBP0.5m (2015: GBP0.2m)
BrainJuicer again proved highly cash generative during 2016. GBP5.2m was returned to shareholders over the 12 months via ordinary and special dividends and share buy-backs, but the Company still ended 2016 with a cash balance of GBP7.8m, equivalent to 63 pence per share, compared with GBP6.4m at end December 2015. BrainJuicer has no debt.
As previously announced, BrainJuicer is changing its financial year end from 31(st) December to 31(st) March. During this transition year, the announcement of unaudited results for 2016 on 9(th) February 2017 will be followed by audited results for the 15 months to 31(st) March 2017, which will be announced in June 2017.
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
The Company can be found at www.brainjuicer.com.
For further information, please contact:
BrainJuicer Group PLC Tel: +44 (0)20 7043 1000 John Kearon, Chief Executive Officer James Geddes, Chief Financial Officer Canaccord Genuity Limited Tel: +44 (0)20 7523 8000 Simon Bridges / Cameron Duncan / Emma Gabriel
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTUKUBRBAAAAAR
(END) Dow Jones Newswires
January 20, 2017 02:00 ET (07:00 GMT)
1 Year Brainjuicer Chart |
1 Month Brainjuicer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions